Table 2.

Clinical response and remission rate at week 6 and week 14 post vedolizumab administration (complete case analysis and analysis with non-response imputation).

Outcomes at week 6	Complete case analysis (n = 77) (%)	Analysis with NRI * (n = 105) (%)
Clinical response rate, n (%)	43 (55.8)	43 (40.1)
Clinical remission rate, n (%)	14 (18.2)	–
Outcomes at week 14	Complete case analysis (n = 71) (%)	Analysis with NRI * (n = 105) (%)
Clinical response rate, n (%)	52 (73.2)	52 (49.5)
Clinical remission rate, n (%)	28 (39.4)	–

^*Clinical response rate at week 6 and week 14 where patients with missing partial Mayo score were assumed to be a non-responder to vedolizumab. “–” means analysis not performed.

NRI, non-response imputation.